28 Day infected vs. control
GeneSymbol Control Avg.Ct ±SEM Infected Avg.Ct ±SEM Foldchange p‐value
Ccl12 6.81 ±0.37 4.39 ±0.51 5.3 0.045
Il13 10.45 ±0.21 11.69 ±0.28 0.4 0.029
Il23a 11.43 ±0.10 10.96 ±0.08 1.4 0.021
35 Day infected vs. control
Bmp7 7.97 ±0.21 6.99 ±0.12 2 0.011
Ccl17 7.11 ±0.52 6.19 ±0.32 6.1 0.021
Cd40lg 13.02 ±0.30 10.40 ±0.36 6.2 0.03
Cx3cl1 5.16 ±0.21 4.16 ±0.18 2 0.025
Cxcl1 12.57 ±0.25 9.99 ±0.24 6 0.007
Fasl 12.75 ±0.66 8.79 ±0.34 15.6 0.019
Gpi1 2.71 ±0.04 1.56 ±0.26 2.2 0.039
Hsp90ab1 0.53 ±0.18 1.98 ±0.26 2.7 0.027
Il12b 13.10 ±0.24 10.47 ±0.17 6.2 0.003
Il1a 11.42 ±0.22 9.65 ±0.23 3.4 0.011
Il9 7.16 ±0.21 8.21 ±0.26 0.5 0.044
Lif 10.03 ±0.38 8.77 ±0.08 2.4 0.016
Mif 1.55 ±0.09 0.17 ±0.29 2.6 0.044
Osm 11.50 ±0.44 9.93 ±0.33 3 0.047
Table 4: Effect of treatment on the expression of mRNAs in the oviduct at 28 and 35 days post‐infection.